Figure 6.
The interrelation of the risk scores and clinicopathological characteristics in gliomas, and the mutational landscape of tumor driver-gene alterations. (A) The relationship between five RNA:m5C methyltransferase expression profiles stratified by risk score and clinicopathological features of gliomas. (B) The relationship between the risk scores and each clinicopathological characteristic. (C) The mutational landscape of tumor driver-gene alterations between low- and high-risk patients with gliomas. Significance: *P < 0.05, **P < 0.01, ***P < 0.001.